These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
543 related items for PubMed ID: 17221151
1. Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J. Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151 [Abstract] [Full Text] [Related]
2. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Johansen J, Overgaard J, Overgaard M. Acta Oncol; 2007 Nov; 46(4):525-33. PubMed ID: 17497320 [Abstract] [Full Text] [Related]
3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):489-95. PubMed ID: 16246495 [Abstract] [Full Text] [Related]
4. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Póti Z, Nemeskéri C, Fekésházy A, Sáfrány G, Bajzik G, Nagy ZP, Bidlek M, Sinkovics I, Udvarhelyi N, Liszkay G, Repa I, Galuska L, Trón L, Mayer A, Esik O. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1022-33. PubMed ID: 15001241 [Abstract] [Full Text] [Related]
5. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Hepel JT, Tokita M, MacAusland SG, Evans SB, Hiatt JR, Price LL, DiPetrillo T, Wazer DE. Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1290-6. PubMed ID: 19395195 [Abstract] [Full Text] [Related]
7. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Kraus-Tiefenbacher U, Bauer L, Scheda A, Fleckenstein K, Keller A, Herskind C, Steil V, Melchert F, Wenz F. Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):377-81. PubMed ID: 16887294 [Abstract] [Full Text] [Related]
8. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE. J Natl Cancer Inst; 2007 Mar 07; 99(5):365-75. PubMed ID: 17341728 [Abstract] [Full Text] [Related]
11. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA. Cancer; 2006 Jun 15; 106(12):2556-62. PubMed ID: 16691617 [Abstract] [Full Text] [Related]
12. A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique. Vass S, Bairati I. Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1274-82. PubMed ID: 16029782 [Abstract] [Full Text] [Related]
13. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up. Bantema-Joppe EJ, Schilstra C, de Bock GH, Dolsma WV, Busz DM, Langendijk JA, Maduro JH. Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):e471-7. PubMed ID: 22494592 [Abstract] [Full Text] [Related]
14. [Radiotherapy and delayed breast reconstruction with implant: examination of compatibility]. Fodor J, Gulyás G, Polgár C, Major T, Szabó E, Köves I, Pólus K, Németh G, Kásler M. Magy Onkol; 2002 Jul 15; 46(4):323-6. PubMed ID: 12563354 [Abstract] [Full Text] [Related]
15. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Gothard L, Cornes P, Earl J, Hall E, MacLaren J, Mortimer P, Peacock J, Peckitt C, Woods M, Yarnold J. Radiother Oncol; 2004 Nov 15; 73(2):133-9. PubMed ID: 15542159 [Abstract] [Full Text] [Related]
16. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Wenz F, Welzel G, Keller A, Blank E, Vorodi F, Herskind C, Tomé O, Sütterlin M, Kraus-Tiefenbacher U. Breast; 2008 Dec 15; 17(6):617-22. PubMed ID: 18650091 [Abstract] [Full Text] [Related]
17. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong. Mak SS, Yeo W, Lee YM, Mo KF, Tse KY, Tse SM, Ho FP, Kwan WH. Nurs Res; 2008 Dec 15; 57(6):416-25. PubMed ID: 19018216 [Abstract] [Full Text] [Related]
18. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, McNeese M, Selwyn BJ, Spitz MR, Bondy ML. Cancer; 2003 Oct 01; 98(7):1457-64. PubMed ID: 14508833 [Abstract] [Full Text] [Related]
19. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results. Knauerhase H, Strietzel M, Gerber B, Reimer T, Fietkau R. Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1048-55. PubMed ID: 18359170 [Abstract] [Full Text] [Related]
20. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples. Andreassen CN, Alsner J, Overgaard M, Sørensen FB, Overgaard J. Int J Radiat Biol; 2006 Aug 15; 82(8):577-86. PubMed ID: 16966185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]